OnePin Peptide Library · Metabolic
5-Amino-1MQ
5-Amino-1-Methylquinolinium · NNMT Inhibitor · 5A1MQ
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor. NNMT is an enzyme highly expressed in white adipose tissue that methylates nicotinamide (a form of vitamin B3/niacin), consuming methyl groups from SAM (S-adenosylmethionine) in the process. NNMT overexpression in adipose tissue drives fat cell maturation, increases adiposity, and depletes the NAD+ salvage pathway by diverting nicotinamide away from NAD+ recycling. By inhibiting NNMT, 5-Amino-1MQ redirects nicotinamide back into the NAD+ salvage pathway, reduces fat cell differentiation, and increases cellular energy metabolism. It is discussed primarily as a body composition optimizer and fat loss agent.
Oral: Take on empty stomach, morning preferred. SubQ: Higher bioavailability. NNMT inhibitor works best fasted for metabolic effects.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
5-Amino-1MQ competitively inhibits NNMT, the enzyme that methylates nicotinamide using SAM as a methyl donor. When NNMT is overactive (as seen in obesity and aging), it diverts nicotinamide away from NAMPT (the rate-limiting enzyme in the NAD+ salvage pathway), depleting cellular NAD+ levels. Simultaneously, NNMT activity drives SAM depletion and polyamine pathway disruption, promoting adipocyte differentiation and lipid accumulation. By blocking NNMT, 5-Amino-1MQ restores nicotinamide flux through the NAD+ salvage pathway (increasing cellular NAD+), reduces SAM-dependent adipogenic signaling, inhibits preadipocyte differentiation into mature fat cells, and increases overall metabolic rate in adipose tissue. The compound shrinks fat cells and prevents new fat cell formation through a completely different mechanism than lipolysis-based approaches (like AOD-9604), making them complementary.
5-Amino-1MQ competitively inhibits NNMT, the enzyme that methylates nicotinamide using SAM as a methyl donor. When NNMT is overactive (as seen in obesity and aging), it diverts nicotinamide away from NAMPT (the rate-limiting enzyme in the NAD+ salvage pathway), depleting cellular NAD+ levels. Simultaneously, NNMT activity drives SAM depletion and polyamine pathway disruption, promoting adipocyte differentiation and lipid accumulation. By blocking NNMT, 5-Amino-1MQ restores nicotinamide flux through the NAD+ salvage pathway (increasing cellular NAD+), reduces SAM-dependent adipogenic signaling, inhibits preadipocyte differentiation into mature fat cells, and increases overall metabolic rate in adipose tissue. The compound shrinks fat cells and prevents new fat cell formation through a completely different mechanism than lipolysis-based approaches (like AOD-9604), making them complementary.
What to expect
Days 1-14: Minimal perceptible changes. NNMT inhibition effects on fat cell biology take weeks to manifest visually. Some users report subtle energy improvements.
Weeks 2-6: Body composition changes may begin to appear with proper diet and exercise. NAD+ salvage pathway restoration effects accumulate.
Weeks 6-12: Cumulative anti-adipogenic effects. Fat mass reduction becomes measurable. Best tracked via DEXA or body composition testing rather than scale weight.
Evidence
The honest take
Fat loss via NNMT inhibition
SupportedAnimal data strongly supports reduced adiposity through NNMT inhibition. Mechanism is well-characterized. Human fat loss data is anecdotal.
Indirect NAD+ boost via restored salvage pathway is mechanistically sound and confirmed in cell studies. Not a direct NAD+ precursor like NMN/NR.
NNMT inhibitors are under active pharmaceutical development. 5-Amino-1MQ is a research tool compound, not a clinical drug candidate itself.
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Side effects & safety
Commonly reported
- Generally well tolerated
- Mild injection site irritation
- Some users report mild energy increase or jitteriness initially
- Rare mild GI discomfort with oral formulation
Less common & notes
- 5-Amino-1MQ is a newer compound with limited long-term safety data.
- NNMT plays roles in cellular methylation beyond adipose tissue, and long-term systemic NNMT inhibition effects are not fully characterized.
- Monitor liver function periodically as NNMT is expressed in liver tissue.
- No significant adverse events reported in animal studies at therapeutic doses.
Pharmacokinetics
Storage. Store unreconstituted vials frozen (-20C) or refrigerated (2-8C). After reconstitution with BAC water, refrigerate at 2-8C. Stable for 28 days. Small molecule with favorable stability. Protect from light.
Regulatory status
5-Amino-1MQ is not FDA-approved for any indication. Available as a research chemical. Not specifically listed on WADA prohibited list. Not a controlled substance. Regulatory status is less established than older peptides.
Put it to work
Calculate, log & track
Open 5-Amino-1MQ straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open 5-Amino-1MQ in the app →Go deeper
The guide & community
The complete 5-Amino-1MQ walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗